Trp53 inactivation in the tumor microenvironment promotes tumor progression by expanding the immunosuppressive lymphoid-like stromal network

Keyphrases

• Tumor Progression 100%
• Tumor Microenvironment 100%
• Trp53 100%
• Wild Mice 80%
• Myeloid-derived Suppressor Cells 60%
• Cell Differentiation 40%
• Spleen 20%
• Tumor Protein p53 (TP53) 20%
• Human Cancer 20%
• Tumor 20%
• Inflammatory Cytokines 20%
• FoxP3+ 20%
• Cell Tumor 20%
• Tumorigenesis 20%
• Immunosuppression 20%
• Tumor Growth 20%
• Chemokines 20%
• Effector Function 20%
• Somatic mutation 20%
• Poor Prognosis 20%
• Regulatory T Cells 20%
• Lymphoid Organs 20%
• Cancer-associated Fibroblasts 20%
• Stromal Cells 20%
• P53 Inactivation 20%
• TP53 mutation 20%
• CD11b+ 20%
• Metastasis Prognosis 20%
• Tumor Establishment 20%
• Immunosuppressive Molecules 20%
• Immunotolerant 20%
• B16F1 20%
• B16F1 Melanoma 20%
• Fibroblastic Reticular Cells 20%
• Tumor-stroma Interaction 20%
• Gr-1 20%

Medicine and Dentistry

• Protein P53 100%
• Tumor Progression 100%
• Immunosuppressive Drug 100%
• Tumor Microenvironment 100%
• Neoplasm 80%
• Suppressor Cell 60%
• Cell Differentiation 40%
• Malignant Neoplasm 20%
• Tumor Suppressor Protein 20%
• Inflammatory Cytokine 20%
• Metastatic Carcinoma 20%
• Chemokine 20%
• Fibroblast 20%
• Nodular Melanoma 20%
• Somatic Mutation 20%
• Immunosuppressive Treatment 20%
• Stroma 20%
• Carcinogenesis 20%
• Stromal Cell 20%
• Lymphoid Organ 20%

Immunology and Microbiology

• P53 100%
• Immunosuppressive Drug 100%
• Wild Type Mouse 80%
• Suppressor Cell 60%
• Mouse 40%
• Cell Differentiation 40%
• Inflammatory Cytokine 20%
• Fibroblast 20%
• Lymphoid Organ 20%
• Chemokine 20%
• Somatic Mutation 20%
• Stroma 20%
• Immunosuppression 20%